Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-026992

Head of Pharm Ops and Tech gave up 39 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 131 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2022-12-02 Option exercise +131 2,807.29 D
Murphy Nicole Head of Pharm Ops and Tech 2022-12-02 Shares withheld for taxes −39 $298.90 $11,657 2,768.29 D
Derivatives
Murphy Nicole Head of Pharm Ops and Tech 2022-12-02 Option exercise · Restricted Stock Unit −131 0 D
Loading xslF345X03/form4.xml…